Skip to main
STML
STML logo

Stemline Therapeutics (STML)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Stemline Therapeutics (STML) Stock

About Stemline Therapeutics (STML)

Stemline Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery, acquisition, development, and commercialization of novel therapeutics for oncology indications of unmet medical need. Its clinical stage product candidates include SL-401, SL-801, and SL-701. The SL-401 is a targeted therapy directed to the interleukin-3 receptor (CD123) present on a malignan...read more
Market cap$621.2M
Today's volume
Revenue (TTM)
Avg. daily volume1.9M
EBITDA (TTM)
Open
Price / earnings ratio-7.47x
Today's range
Debt / equity
52 week range$3.21 - $18.22
5 year debt / equity0.03x
Beta (LTM)1.08x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsMar 13, 2020
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jul 17, 2025, the market cap for STML stock is $621.21M

The current P/E ratio for STML stock is -7.47

The 52-week high for STML stock is $18.22. The current STML stock price $undefined is 100.00% below its 52-week high

The 52-week low for STML stock is $3.21. The current STML stock price $undefined has increased 100.00% from its 52-week low

No, the STML stock does not pay dividends to its shareholders

How to buy STML stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in STML stock

    Navigate to the Explore page. Then, type STML into the search bar. When you see STML stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased STML stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Stemline Therapeutics Stock Earnings

The value each STML share was expected to gain vs. the value that each STML share actually gained.

Stemline Therapeutics (STML) reported Q4 2019 earnings per share (EPS) of -$0.38, missing estimates of -$0.35 by 8.57%. In the same quarter last year, Stemline Therapeutics's earnings per share (EPS) was $0. Stemline Therapeutics is expected to release next earnings on 03/13/2020, with an earnings per share (EPS) estimate of $0.

Buy Stemline Therapeutics (STML) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.